How to buy Ensidipine

Enasidenib, which targetsIDH2, was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have an IDH2 mutation detected by an FDAapproved test. Ensiidi plain medicine is not currently on the market in China, so it is not sold in domestic hospitals or pharmacies. It can only be purchased through overseas channels. Encidipine generic drugs and generic drugs are sold overseas. The ingredients of the two drugs are basically the same, but there may be some differences in manufacturers, specifications, etc. For more information on overseas drug prices and specific information, please consult Yaode Medical Consultant.